Cargando…

A novel synthetic DNA vaccine elicits protective immune responses against Powassan virus

Powassan virus (POWV) infection is a tick-borne emerging infectious disease in the United States and North America. Like Zika virus, POWV is a member of the family Flaviviridae. POWV causes severe neurological sequalae, meningitis, encephalitis, and can cause death. Although the risk of human POWV i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choi, Hyeree, Kudchodkar, Sagar B., Ho, Michelle, Reuschel, Emma L., Reynolds, Erin, Xu, Ziyang, Bordoloi, Devivasha, Ugen, Kenneth E., Tebas, Pablo, Kim, Joseph, Abdel-Mohsen, Mohamed, Thangamani, Saravanan, Weiner, David B., Muthumani, Kar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7595275/ https://www.ncbi.nlm.nih.gov/pubmed/33119599 http://dx.doi.org/10.1371/journal.pntd.0008788

Ejemplares similares

Ecology of Powassan Virus in the United States
por: Hassett, Erin M., et al.
Publicado: (2021)

Rapid response to an emerging infectious disease – Lessons learned from development of a synthetic DNA vaccine targeting Zika virus
por: Kudchodkar, Sagar B., et al.
Publicado: (2018)

Immunotherapy of prostate cancer using novel synthetic DNA vaccines targeting multiple tumor antigens
por: Bordoloi, Devivasha, et al.
Publicado: (2021)

Synthetic nucleic acid antibody prophylaxis confers rapid and durable protective immunity against Zika virus challenge
por: Choi, Hyeree, et al.
Publicado: (2019)

Expanding the Reach of Monoclonal Antibodies: A Review of Synthetic Nucleic Acid Delivery in Immunotherapy
por: Chung, Christopher, et al.
Publicado: (2023)

Neutralization of hepatitis B virus by a novel DNA-encoded monoclonal antibody
por: Zankharia, Urvi S., et al.
Publicado: (2020)

Synthetic DNA Vaccines: Improved Vaccine Potency by Electroporation and Co-Delivered Genetic Adjuvants
por: Flingai, Seleeke, et al.
Publicado: (2013)

Development of Siglec-9 Blocking Antibody to Enhance Anti-Tumor Immunity
por: Choi, Hyeree, et al.
Publicado: (2021)

Salivary gland extract from the deer tick, Ixodes scapularis, facilitates neuroinvasion by Powassan virus in BALB/c mice
por: Santos, Rodrigo I., et al.
Publicado: (2021)

Co-Administration of Molecular Adjuvants Expressing NF-Kappa B Subunit p65/RelA or Type-1 Transactivator T-bet Enhance Antigen Specific DNA Vaccine-Induced Immunity
por: Shedlock, Devon J., et al.
Publicado: (2014)

Proinflammatory Cytokines and Chemokines at the Skin Interface during Powassan Virus Transmission
por: Hermance, Meghan E, et al.
Publicado: (2014)

Powassan Virus: An Emerging Arbovirus of Public Health Concern in North America
por: Hermance, Meghan E., et al.
Publicado: (2017)

Protective immunity by an engineered DNA vaccine for Mayaro virus
por: Choi, Hyeree, et al.
Publicado: (2019)

ZIKA-001: Safety and Immunogenicity of an Engineered DNA Vaccine Against ZIKA virus infection
por: Tebas, Pablo, et al.
Publicado: (2017)

Powassan Virus Lineage I in Field-Collected Dermacentor variabilis Ticks, New York, USA
por: Hart, Charles, et al.
Publicado: (2023)

Tick Saliva Enhances Powassan Virus Transmission to the Host, Influencing Its Dissemination and the Course of Disease
por: Hermance, Meghan E., et al.
Publicado: (2015)

Novel prostate cancer immunotherapy with a DNA-encoded anti-prostate-specific membrane antigen monoclonal antibody
por: Muthumani, Kar, et al.
Publicado: (2017)

Landscape of humoral immune responses against SARS-CoV-2 in patients with COVID-19 disease and the value of antibody testing
por: Mahalingam, Sundarasamy, et al.
Publicado: (2021)

Utilization of RNA in situ Hybridization to Understand the Cellular Localization of Powassan Virus RNA at the Tick-Virus-Host Interface
por: Hermance, Meghan E., et al.
Publicado: (2020)

Infection with Borrelia burgdorferi Increases the Replication and Dissemination of Coinfecting Powassan Virus in Ixodes scapularis Ticks
por: Hart, Charles E., et al.
Publicado: (2022)

Spinal Cord Ventral Horns and Lymphoid Organ Involvement in Powassan Virus Infection in a Mouse Model
por: Santos, Rodrigo I., et al.
Publicado: (2016)

Ixodes scapularis salivary gland microRNAs are differentially expressed during Powassan virus transmission
por: Hermance, Meghan E., et al.
Publicado: (2019)

Immune Cell Targets of Infection at the Tick-Skin Interface during Powassan Virus Transmission
por: Hermance, Meghan E., et al.
Publicado: (2016)

Synthetic DNA delivery by electroporation promotes robust in vivo sulfation of broadly neutralizing anti-HIV immunoadhesin eCD4-Ig
por: Xu, Ziyang, et al.
Publicado: (2018)

436. Developing a Synthetic DNA Vaccine for an Emerging Pathogen - Middle East Respiratory Syndrome
por: Reuschel, Emma L., et al.
Publicado: (2016)

Designed DNA-Encoded IL-36 Gamma Acts as a Potent Molecular Adjuvant Enhancing Zika Synthetic DNA Vaccine-Induced Immunity and Protection in a Lethal Challenge Model
por: Louis, Lumena, et al.
Publicado: (2019)

Rapid and Long-Term Immunity Elicited by DNA-Encoded Antibody Prophylaxis and DNA Vaccination Against Chikungunya Virus
por: Muthumani, Karuppiah, et al.
Publicado: (2016)

Identification of Novel Neutralizing Monoclonal Antibodies against SARS-CoV-2 Spike Glycoprotein
por: Bordoloi, Devivasha, et al.
Publicado: (2021)

A synthetic consensus anti-Spike protein DNA vaccine induces protective immunity against Middle East Respiratory Syndrome Coronavirus in non-human primates
por: Muthumani, K., et al.
Publicado: (2016)

Development of Novel DNA-Encoded PCSK9 Monoclonal Antibodies as Lipid-Lowering Therapeutics
por: Khoshnejad, Makan, et al.
Publicado: (2019)

Harnessing Recent Advances in Synthetic DNA and Electroporation Technologies for Rapid Vaccine Development Against COVID-19 and Other Emerging Infectious Diseases
por: Xu, Ziyang, et al.
Publicado: (2020)

A Powassan virus domain III nanoparticle immunogen elicits neutralizing and protective antibodies in mice
por: Malonis, Ryan J., et al.
Publicado: (2022)

Simplifying checkpoint inhibitor delivery through in vivo generation of synthetic DNA-encoded monoclonal antibodies (DMAbs)
por: Perales-Puchalt, Alfredo, et al.
Publicado: (2019)

Powassan Virus Encephalitis, Minnesota, USA
por: Neitzel, David F., et al.
Publicado: (2013)

Powassan Virus Encephalitis, Minnesota, USA
por: Birge, Justin, et al.
Publicado: (2012)

Notes from the Field: Powassan Virus Disease in an Infant — Connecticut, 2016
por: Tutolo, Jessica W., et al.
Publicado: (2017)

Molecular epidemiology of Powassan virus in North America
por: Pesko, Kendra N., et al.
Publicado: (2010)

Incrimination of shrews as a reservoir for Powassan virus
por: Goethert, Heidi K., et al.
Publicado: (2021)

Powassan virus persistence after acute infection
por: Telford, Sam R., et al.
Publicado: (2023)

Synthetic DNA Delivery of an Engineered Arginase Enzyme Can Modulate Specific Immunity In Vivo
por: Khoshnejad, Makan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tfkacv38kpbqea3bprk64vsuvg